Loading organizations...
§ Private Profile · 375 Avenue du Mistral, Bât. B 13600 - La Ciotat - France
AI software company developing deep learning tools for emergency radiology to detect life-threatening pathologies in CT scans.
Based in La Ciotat, France, Avicenna.ai develops artificial intelligence software that utilizes deep learning algorithms to analyze CT scans and prioritize life-threatening pathologies for emergency radiology departments. The company provides a comprehensive suite of clinical workflow tools, such as CINA-ICH and CINA-PE, which automate routine radiologist tasks and deliver diagnostic alerts to clinicians within seconds. Operating on an asset-light business-to-business software licensing model, the enterprise has secured multiple FDA clearances and deployed its medical imaging solutions to more than 140 hospitals across 14 countries globally. Avicenna.ai has raised approximately $10 million in total equity funding to date, including a €7 million Series A financing round backed by institutional investors such as Innovacom, CEMAG Invest, and Exotrail. The medical technology organization was officially founded in the year 2018 by chief executive officer Cyril Di Grandi and radiologist Peter Chang.
Avicenna.ai has raised $11.0M across 2 funding rounds.
Avicenna.ai has raised $11.0M in total across 2 funding rounds.
Avicenna.AI is a technology company specializing in artificial intelligence solutions for emergency radiology. It develops AI-powered tools that assist radiologists by automating the detection and prioritization of urgent cases in CT scans, thereby accelerating diagnosis and improving patient outcomes. Its products serve hospitals, healthcare networks, and teleradiology groups by integrating seamlessly into existing radiology workflows to optimize efficiency and resource allocation in emergency imaging[1][2][3][4].
Founded by experts combining medical and software engineering knowledge, Avicenna.AI emerged from the need to reduce radiologists' manual workload and improve triage accuracy in emergency settings. Early traction came from its ability to deliver fast, reliable AI insights that prioritize critical cases without disrupting clinical workflows. The company has since evolved to launch the AVI platform, which enables plug-and-play integration of multiple AI imaging applications, enhancing scalability and ease of deployment across healthcare systems[1][2][7].
Avicenna.AI rides the growing trend of AI adoption in healthcare, particularly in medical imaging where demand for faster, more accurate diagnostics is rising due to increasing imaging volumes and clinician shortages. The timing is critical as healthcare systems worldwide seek scalable, cost-effective AI solutions that integrate smoothly into existing infrastructures. Avicenna.AI’s focus on emergency radiology addresses a high-impact niche where timely diagnosis can significantly affect patient outcomes. Their platform approach also supports the broader ecosystem by enabling multiple AI applications to coexist and scale within healthcare networks[2][3][7].
Looking ahead, Avicenna.AI is positioned to expand its AI platform capabilities and portfolio of imaging applications, potentially broadening into other radiology domains beyond emergency care. Trends such as increased AI regulatory clarity, growing acceptance of AI in clinical decision-making, and healthcare digitization will shape its trajectory. The company’s emphasis on seamless integration and regulatory compliance will likely enhance adoption and influence in the medical imaging AI market, contributing to faster, more efficient radiology services globally[2][5][7]. This aligns with their mission to revolutionize care through AI-driven radiology solutions that improve patient outcomes and healthcare efficiency.
Avicenna.ai has raised $11.0M in total across 2 funding rounds.
Avicenna.ai's investors include Innovacom, Cemag Invest, Bruno Maisonnier.
Avicenna.ai has raised $11.0M across 2 funding rounds. Most recently, it raised $8.0M Series A in February 2023.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Feb 1, 2023 | $8M Series A | Innovacom, Cemag Invest | Bruno Maisonnier | Announced |
| Feb 1, 2020 | $3M Seed | — | Innovacom, Bruno Maisonnier | Announced |